Cited by

• Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by Insulin-like Growth Factor I.

  Castilla-Cortázar I, Pascual M, Urdaneta E, Pardo J, Puche JE, Vivas B, Díaz-Casares A, García M, Díaz-Sánchez M, Varela-Nieto I, Castilla A, González-Barón S. Castilla-Cortázar I, et al. BMC Gastroenterol. 2004 Jun 14;4:12. doi: 10.1186/1471-230X-4-12. BMC Gastroenterol. 2004. PMID: 15196310 Free PMC article.
• Serum concentrations of insulin-like growth factor-I (igf-I) as a marker of liver fibrosis in patients with chronic hepatitis C.

  Lorenzo-Zúñiga V, Bartolí R, Masnou H, Montoliu S, Morillas RM, Planas R. Lorenzo-Zúñiga V, et al. Dig Dis Sci. 2007 Nov;52(11):3245-50. doi: 10.1007/s10620-006-9437-1. Epub 2007 Apr 5. Dig Dis Sci. 2007. PMID: 17410466
• Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma.

  Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO. Abdel-Wahab R, et al. J Hepatocell Carcinoma. 2015 Sep 18;2:131-42. doi: 10.2147/JHC.S81309. eCollection 2015. J Hepatocell Carcinoma. 2015. PMID: 27508202 Free PMC article. Review.
• Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis.

  Cemborain A, Castilla-Cortázar I, García M, Muguerza B, Delgado G, Díaz-Sánchez M, Picardi A. Cemborain A, et al. J Physiol Biochem. 2000 Jun;56(2):91-9. doi: 10.1007/BF03179904. J Physiol Biochem. 2000. PMID: 11014614
• Hematotesticular barrier is altered from early stages of liver cirrhosis: effect of insulin-like growth factor 1.

  Castilla-Cortazar I, Diez N, Garcia-Fernandez M, Puche JE, Diez-Caballero F, Quiroga J, Diaz-Sanchez M, Castilla A, Casares AD, Varela-Nieto I, Prieto J, Gonzalez-Baron S. Castilla-Cortazar I, et al. World J Gastroenterol. 2004 Sep 1;10(17):2529-34. doi: 10.3748/wjg.v10.i17.2529. World J Gastroenterol. 2004. PMID: 15300898 Free PMC article.